for Retinal Vasculopathy with Cerebral Leukoencephalopathy (RVCL) and maintain long-term ongoing research grants with the University of Pennsylvania, The university of Michigan and Washington University. The space between scientific potential and human application can broadly be categorized as “academic research.” Without this important bridge, new advancements would cease to exist, hope would wane, and RVCL would continue unchecked. Fortunately, scientific progress exists, and we are excited to be a part of such a revolution. Favor fortunes the brave, and we love to support researchers who have innovative ideas and projects that may one day clinically benefit RVCL patients.
Currently, we are supporting several active research projects which have the potential for great knowledge to be gained and clinical advancements achieved.